COVID-19 Vaccines

As a service to our clients, we are now offering this COMPLEMENTARY course!  It will be available to you upon purchase of any course materials from ASI!  No date(s) or location(s) will be documented for any free course. 

This Activity is Jointly Provided by Global Education Group and American Seminar Institute

Short Course:  1 AMA PRA Category 1 Credits for CME / CEU / CPD; (Launched 4/12/21; Expires 4/11/22)

Target Audience:  The educational design of this activity addresses the needs of any health care worker that consults, advises or administers patients on COVID-19 vaccinations and will benefit from taking this course.

Series 1 (MCOVID-19-1)
 
The present pandemic resulting from the rapid emergence and spread of the unique virus, known as SARS-CoV-2 causing COVID-19 disease, has been catastrophic to society. Numerous vaccines are under development simultaneously. The seminar will talk through the development of vaccine, from inception through approval and implementation. Throughout the talk, some of the most common concerns and questions regarding COVID-19 vaccines will be addressed. This seminar is intended to inform the audience regarding the true public health value of these vaccines.
 
Short Course:
MCOVID-19-1
Short Course Price:
$0
Format:
Available in Video format.
Only Available Option: Short Course/Part A

Instructor Bio

Wilbur H. Chen, MD, MS, FACP, FIDSA

Biosketch
 
Dr. Chen is an adult infectious disease physician-scientist with a specific interest in clinical vaccinology. He is Chief of the Adult Clinical Studies section within the Center for Vaccine Development and Global Health and Director of the UMB Travel Medicine Practice. His research is concentrated on two areas of global health importance. First, he is devoted to developing vaccines for enteric pathogens, infectious diseases chiefly of resource poor and economically disadvantaged countries and populations. Second, he is interested in developing improved vaccines for the elderly, a rapidly growing segment of the global population which is susceptible to many infections and a special population that generally responds poorly to vaccination.
 
Dr. Chen is active investigator within the NIAID-supported Vaccine and Treatment Evaluation Unit (VTEU), composed of 9 academic centers throughout the U.S., and was the principal investigator of the NIAID-supported Food and Waterborne Diseases Integrated Research Network Clinical Research Unit (FWD IRN CRU). He has been a PI on vaccine trials for: influenza viruses (Seasonal, Pandemic 2009 H1N1, Avian H5N1, and Avian H7N9 influenza), agents of bioterror (Tularemia and Staphylococcal enterotoxin B), and enteric pathogens (typhoid, cholera and enterotoxigenic E. coli)-including human experimental challenge studies with wild-type V. cholerae and enterotoxigenic E. coli (ETEC).
 
In collaboration with PATH (an international nonprofit organization, Program for Appropriate Technology in Health), Dr. Chen has imminent research projects evaluating a meningococcal vaccine, Shigella vaccines, and developing a human challenge model with heat-stable enterotoxin (ST)-only expressing ETEC. With funding from the Bill & Melinda Gates Foundation, Dr. Chen is also developing a human challenge model with Cryptosporidium hominis.
 
Education and Training
 
Boston University, B.A., Biology, 1992
 
Howard University College of Medicine, M.D., 1999
 
Residency, Johns Hopkins University Bayview Medical Center, Internal Medicine, 1999-2002
 
Fellowship, University of Maryland Medical Center, Infectious Diseases, 2002-2004
 
Fellowship, University of Maryland Center for Vaccine Development, National Research Service Award in Vaccinology, 2004-2006
 
University of Maryland, M.S., Clinical Research, 2008

Course Topics

Development of Vaccines

Discovery

Vaccine Platforms

Stages of Clinical Development

Approval

Vaccine Policy

Vaccine Implementation

FAQs

Conclusion

Course Objectives

After completing this activity, the participant should be better able to:

  • Review COVID-19 vaccine development
  • Explain how to counsel patients about the COVID-19 vaccine
  • Predict patient questions in depth and properly advise them
 

Accreditation

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and American Seminar Institute.  Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Term of Offering
This activity was released on April 12, 2021 and is valid for one year. Requests for credit must be made no later than April 11, 2022. 
 
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
 
Instructions to Receive Credit
In order to receive credit for this activity, the participant must watch the content video, score 70% or higher on the posttest, and complete the program evaluation. Only learners who have a passing score and complete the evaluation will receive a CME certificate.
 
Disclosure of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.  
 
All relevant financial relationships have been mitigated. 
 
The faculty have the following relevant financial relationships with ineligible companies:
 
Name of Faculty or Presenter Reported Financial Relationship
Wilbur H. Chen, MD, MS, FACP, FIDSA Nothing to disclose
 
The planners and managers have the following relevant financial relationships with ineligible companies:
 
Name of Planner or Manager Reported Financial Relationship
Lindsay Borvansky:  Nothing to disclose
Andrea Funk:  Nothing to disclose
Liddy Knight:  Nothing to disclose
Ashley Cann:  Nothing to disclose
Josh Buchman:  Nothing to disclose
 
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and American Seminar Institute do not recommend the use of any agent outside of the labeled indications.  
 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
 
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
 
 

Additional Information

PC

Microsoft Windows 2000 SE or above.
Flash Player Plugin (v7.0.1.9 or greater)
Internet Explorer (v5.5 or greater), or Firefox
Adobe Acrobat Reader* 
 
MAC
MAC OS 10.2.8
Flash Player Plugin (v7.0.1.9 or greater)
Safari
Adobe Acrobat Reader*
Internet Explorer is not supported on the Macintosh. 
 
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.

Specialty

Interactive Courses

video (mp4)